SNHG8
gene geneOn this page
Also known as NCRNA00060LINC00060
Summary
SNHG8 (small nucleolar RNA host gene 8, HGNC:33098) is a long non-coding RNA gene on chromosome 4q26.
Predicted to be involved in RNA processing. Predicted to be located in nucleolus.
Source: NCBI Gene 100093630 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33098 |
| Approved symbol | SNHG8 |
| Name | small nucleolar RNA host gene 8 |
| Location | 4q26 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | NCRNA00060, LINC00060 |
| Ensembl gene | ENSG00000269893 |
| Ensembl biotype | lncRNA |
| Entrez | 100093630 |
| RNAcentral | URS000075B0C9 — lncRNA, 653 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 33 — 33 lncRNA
ENST00000602414, ENST00000602483, ENST00000602520, ENST00000602573, ENST00000602819, ENST00000652022, ENST00000654083, ENST00000665363, ENST00000685544, ENST00000685751, ENST00000688996, ENST00000689575, ENST00000689845, ENST00000693179, ENST00000693401, ENST00000729024, ENST00000729025, ENST00000729026, ENST00000729027, ENST00000729028, ENST00000729029, ENST00000729030, ENST00000729031, ENST00000729032, ENST00000729033, ENST00000729034, ENST00000729035, ENST00000729036, ENST00000729037, ENST00000729038, ENST00000729039, ENST00000729040, ENST00000729041
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000602414 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003455973 | 118279389 | 118279431 |
| ENSE00003859447 | 118278934 | 118279137 |
| ENSE00004056127 | 118278728 | 118278792 |
| ENSE00004056132 | 118279624 | 118279829 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 99.38.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 126.6619 / max 2787.6970, expressed in 1814 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 49421 | 122.6568 | 1814 |
| 49420 | 4.0051 | 1240 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 99.38 | gold quality |
| left ovary | UBERON:0002119 | 99.29 | gold quality |
| ovary | UBERON:0000992 | 99.21 | gold quality |
| right uterine tube | UBERON:0001302 | 99.02 | gold quality |
| skin of abdomen | UBERON:0001416 | 98.99 | gold quality |
| right ovary | UBERON:0002118 | 98.94 | gold quality |
| zone of skin | UBERON:0000014 | 98.85 | gold quality |
| prostate gland | UBERON:0002367 | 98.85 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.82 | gold quality |
| skin of leg | UBERON:0001511 | 98.81 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 98.78 | gold quality |
| endocervix | UBERON:0000458 | 98.76 | gold quality |
| pituitary gland | UBERON:0000007 | 98.75 | gold quality |
| pancreas | UBERON:0001264 | 98.75 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.72 | gold quality |
| body of stomach | UBERON:0001161 | 98.72 | gold quality |
| nucleus accumbens | UBERON:0001882 | 98.71 | gold quality |
| vagina | UBERON:0000996 | 98.70 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.69 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.68 | gold quality |
| thyroid gland | UBERON:0002046 | 98.66 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 98.66 | gold quality |
| fallopian tube | UBERON:0003889 | 98.51 | gold quality |
| uterine cervix | UBERON:0000002 | 98.49 | gold quality |
| fundus of stomach | UBERON:0001160 | 98.48 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 98.47 | gold quality |
| tibial nerve | UBERON:0001323 | 98.47 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 98.44 | gold quality |
| minor salivary gland | UBERON:0001830 | 98.42 | gold quality |
| omental fat pad | UBERON:0010414 | 98.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 13.37 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 24)
- SNHG8 is highly expressed in endometrial carcinoma, and SNHG8 targets c-MET through miR-152 to regulate the proliferation of endometrial cancer cells. (PMID:29630089)
- These data indicate the pro-oncogenic potential of SNHG8 in EBV-associated gastric carcinoma, meaning it is a latent therapeutic target for the treatment of this type of cancer. (PMID:29736176)
- The expression levels of lncRNA SNHG8 were dramatically increased in hepatocellular carcinoma (HCC) tissues and cell lines as compared with the adjacent normal tissues, and SNHG8 expression was an independent prognostic factor of tumor recurrence in HCC patients. SNHG8 acted as a sponge of miR-149 and counteracted the tumor suppressive effects of mi R-149. (PMID:30537734)
- SNHG8 was up-regulated in colorectal cancer and promoted the proliferation, migration, and invasion of colorectal cancer by sponging miR-663. (PMID:31152930)
- identified as a key regulator of acute myocardial infarction by RNA-seq analysis (PMID:31739782)
- LncRNA SNHG8 accelerates proliferation and inhibits apoptosis in HPV-induced cervical cancer through recruiting EZH2 to epigenetically silence RECK expression. (PMID:31961005)
- Long noncoding RNA SNHG8 promotes the proliferation of osteosarcoma cells by downregulating miR-542-3p. (PMID:32450677)
- LncRNA SNHG8 induces ovarian carcinoma cells cellular process and stemness through Wnt/beta-catenin pathway. (PMID:32538821)
- lncRNA SNHG8 promotes aggressive behaviors of nasopharyngeal carcinoma via regulating miR-656-3p/SATB1 axis. (PMID:32920509)
- LncRNA SNHG8 promotes cell migration and invasion in breast cancer cell through miR-634/ZBTB20 axis. (PMID:33275231)
- Long non-coding RNA SNHG8 promotes prostate cancer progression through repressing miR-384 and up-regulating HOXB7. (PMID:33450101)
- Loss of lncRNA SNHG8 promotes epithelial-mesenchymal transition by destabilizing CDH1 mRNA. (PMID:33754289)
- Small nucleolar RNA host gene 8: A rising star in the targets for cancer therapy. (PMID:33894626)
- Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis. (PMID:34362407)
- Differentiated expression of long non-coding RNA-small nucleolar RNA host gene 8 in atherosclerosis and its molecular mechanism. (PMID:34558393)
- Knockdown of long non-coding RNA SNHG8 suppresses the progression of esophageal cancer by regulating miR-1270/BACH1 axis. (PMID:35067159)
- SNHG8 promotes cell proliferation, migration, and invasion of nasopharyngeal carcinoma cells as an oncogene through miR-588/HMGA2 axis. (PMID:35080988)
- YY1-induced long non-coding RNA small nucleolar RNA host gene 8 promotes the tumorigenesis of melanoma via the microRNA-656-3p/SERPINE1 mRNA binding protein 1 axis. (PMID:35156513)
- Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression. (PMID:35354542)
- [Matrix stiffening related lncRNA SNHG8 regulates chemosensitivity of ovarian cancer]. (PMID:36854552)
- A review on the role of SNHG8 in human disorders. (PMID:37043963)
- Long non-coding RNA SNHG8 drives stress granule formation in tauopathies. (PMID:37730840)
- LncRNA SNHG8 regulates the migration and angiogenesis of pHUVECs induced by high glucose via the TRPM7/ERK1/2 signaling axis. (PMID:38110485)
- The lncRNAs Gas5, MALAT1 and SNHG8 as diagnostic biomarkers for epithelial malignant pleural mesothelioma in Egyptian patients. (PMID:38413635)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.